We were the first to report that the cGAS selective inhibitor RU.521 ameliorates subarachnoid hemorrhage-induced brain injury via regulating microglial polarization and neuroinflammation mediated by the cGAS/STING/NF-κB pathway. Here, CGAS is linked to subarachnoid hemorrhage.